BMY 25368
Alternative Names: SKF 94482Latest Information Update: 30 Nov 1993
At a glance
- Originator Bristol-Myers Squibb
- Class Antihistamines; Antiulcers
- Mechanism of Action Histamine H2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastric ulcer
Most Recent Events
- 30 Nov 1993 Discontinued-III for Gastric ulcer in USA (Unknown route)